Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Altamira Therapeutics' Zbtb46 mRNA Nanoparticles Show Significant Tumor Growth Reduction And Long-Term Remission When Combined With Anti-PD1 Therapy

Author: Benzinga Newsdesk | August 12, 2024 09:04am

Results Published In Nature Immunology Highlight Potential To Enhance Effectiveness Of Immune Checkpoint Inhibitors

Posted In: CYTO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist